NO312899B1 - Aminodihydro-oksopurinyl-metoksypropandiolderivater - Google Patents

Aminodihydro-oksopurinyl-metoksypropandiolderivater Download PDF

Info

Publication number: NO312899B1
Authority: NO; Norway
Prior art keywords: amino; methoxy; dihydro; oxopurin; hydroxy
Prior art date: 1994-07-28

Application number

NO19952977A

Other languages

English (en)

Norwegian (no)

Other versions

NO952977D0 (no

NO952977L (no

Inventor

John J Nestor

Scott W Womble

Hans Maag

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-07-28

Filing date

1995-07-27

Publication date

2002-07-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23079211&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO312899(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1995-07-27 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

1995-07-27 Publication of NO952977D0 publication Critical patent/NO952977D0/no

1996-01-29 Publication of NO952977L publication Critical patent/NO952977L/no

2002-07-15 Publication of NO312899B1 publication Critical patent/NO312899B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Virology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biotechnology (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Peptides Or Proteins (AREA)
Saccharide Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Hydrogenated Pyridines (AREA)

NO19952977A 1994-07-28 1995-07-27 Aminodihydro-oksopurinyl-metoksypropandiolderivater NO312899B1 (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US28189394A	1994-07-28	1994-07-28

Publications (3)

Publication Number	Publication Date
NO952977D0 NO952977D0 (no)	1995-07-27
NO952977L NO952977L (no)	1996-01-29
NO312899B1 true NO312899B1 (no)	2002-07-15

Family

ID=23079211

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
NO19952977A NO312899B1 (no)	1994-07-28	1995-07-27	Aminodihydro-oksopurinyl-metoksypropandiolderivater
NO2003001C NO2003001I2 (no)	1994-07-28	2003-01-10	Valganciklovir

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
NO2003001C NO2003001I2 (no)	1994-07-28	2003-01-10	Valganciklovir

Country Status (33)

Country	Link
EP (1)	EP0694547B1 (fr)
JP (1)	JP3090305B2 (fr)
KR (1)	KR100358626B1 (fr)
CN (1)	CN1045089C (fr)
AT (1)	ATE179173T1 (fr)
AU (1)	AU697107B2 (fr)
BR (1)	BR9503468A (fr)
CA (1)	CA2154721C (fr)
CO (1)	CO4410181A1 (fr)
CY (2)	CY2180B1 (fr)
CZ (1)	CZ290511B6 (fr)
DE (3)	DE69509173T2 (fr)
DK (1)	DK0694547T3 (fr)
ES (1)	ES2083348T3 (fr)
FI (1)	FI112080B (fr)
GR (2)	GR960300021T1 (fr)
HK (1)	HK1012339A1 (fr)
HU (1)	HU216867B (fr)
IL (1)	IL114735A (fr)
LU (1)	LU91136I2 (fr)
MA (1)	MA23631A1 (fr)
MY (1)	MY114393A (fr)
NL (1)	NL300071I2 (fr)
NO (2)	NO312899B1 (fr)
NZ (1)	NZ272652A (fr)
PE (1)	PE32296A1 (fr)
PL (1)	PL180609B1 (fr)
RU (1)	RU2133749C1 (fr)
SA (1)	SA95160158B1 (fr)
TR (1)	TR199500895A2 (fr)
TW (1)	TW434242B (fr)
UY (1)	UY24006A1 (fr)
ZA (1)	ZA956228B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6458772B1 (en)	1909-10-07	2002-10-01	Medivir Ab	Prodrugs
US5840890A (en) *	1996-01-26	1998-11-24	Syntex (U.S.A.) Inc.	Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
US5700936A (en) *	1996-01-26	1997-12-23	Syntex (U.S.A.) Inc.	Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol valinate
AU1543797A (en) *	1996-01-26	1997-08-20	F. Hoffmann-La Roche Ag	Process for preparing purine derivatives
US5756736A (en) *	1996-01-26	1998-05-26	Syntex (U.S.A.) Inc.	Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
AU1592897A (en) *	1996-01-26	1997-08-20	F. Hoffmann-La Roche Ag	Process for preparing purine derivatives
US6703394B2 (en)	1996-02-16	2004-03-09	Medivir Ab	Acyclic nucleoside derivatives
US5869493A (en) *	1996-02-16	1999-02-09	Medivir Ab	Acyclic nucleoside derivatives
US6184376B1 (en)	1997-02-10	2001-02-06	Mediver Ab	Synthesis of acyclic nucleoside derivatives
ES2186127T3 (es) *	1997-02-10	2003-05-01	Medivir Ab	Sintesis de derivados de nucleosidos aciclicos.
CN1130362C (zh) *	1997-08-15	2003-12-10	美迪维尔公司	核苷类似物,这些化合物作为包括乙型肝炎病毒(hbv)的逆转录病毒的逆转录酶及dna聚合酶抑制剂的抗病毒药
WO1999032490A1 (fr) *	1997-12-19	1999-07-01	Bristol-Myers Squibb Company	Promedicaments du lobucavir et leur mode d'utilisation
WO1999051613A1 (fr) *	1998-04-03	1999-10-14	Medivir Ab	Promedicaments de produits pharmaceutiques contenant du phosphore
KR20030015655A (ko) *	2001-08-17	2003-02-25	한미약품공업 주식회사	항암제의 경구흡수율을 증가시키는 인단계 화합물의결정성 산부가염, 이의 제조방법 및 이를 함유하는 약학적조성물
DE60313769T2 (de) *	2002-04-23	2008-03-06	Aventis Pharmaceuticals Inc.	3-(pyridinyl-amino)-1h-indol-2-carbonsäure-verbindungen als inhibitoren der interleukin-4 genexpression
ES2534713T3 (es)	2002-10-16	2015-04-27	Takeda Pharmaceutical Company Limited	Preparaciones sólidas estables
ATE398455T1 (de)	2003-01-14	2008-07-15	Gilead Sciences Inc	Zusammensetzungen und verfahren zur antiviralen kombinationstherapie
EP1660499A1 (fr) *	2003-08-28	2006-05-31	Ranbaxy Laboratories Limited	Chlorhydrate de valganciclovir amorphe
JP5563735B2 (ja)	2004-06-16	2014-07-30	タケダファーマシューティカルズユー．エス．エー．インコーポレイティド	Ｐｐｉ多回剤形
CN101027318B (zh) *	2004-07-19	2016-05-25	比奥孔有限公司	胰岛素-低聚物共轭物，制剂及其用途
TWI471145B (zh)	2005-06-13	2015-02-01	Bristol Myers Squibb & Gilead Sciences Llc	單一式藥學劑量型
TWI375560B (en)	2005-06-13	2012-11-01	Gilead Sciences Inc	Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same
ZA200702234B (en) *	2006-03-21	2008-07-30	Cipla Ltd	Preparation of ester of purine derivatives
KR20100116165A (ko)	2007-10-12	2010-10-29	다케다 파마슈티칼스 노쓰 어메리카, 인코포레이티드	음식 섭취와 관계없이 위장 장애를 치료하는 방법
CN103562207B (zh) *	2011-05-31	2016-08-17	法尔玛赞公司	用于制备缬更昔洛韦的2-氨基-9-((2-苯基-1，3-二噁烷-5-基氧基)甲基)-1h-嘌呤-6(9h)-酮化合物的制备方法
KR102312533B1 (ko)	2021-02-24	2021-10-15	주식회사 이웅	자동 스패너

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL8202626A (nl) *	1982-06-29	1984-01-16	Stichting Rega V Z W	Derivaten van 9-(2-hydroxyethoxymethyl)guanine.
IE842642L (en) *	1983-10-31	1985-04-30	Harvard College	Purine Derivatives
EP0187297B1 (fr) *	1984-12-12	1991-08-21	Syntex (U.S.A.) Inc.	Dérivés d'éther alcoxyméthylique et d'esters alcoxyméthyliques
AP160A (en) *	1987-08-15	1991-11-18	The Wellcome Foundation Ltd	Therapeutic acyclic nucleosides.
EP0375329B1 (fr) *	1988-12-19	1995-05-31	The Wellcome Foundation Limited	Dérivés antiviraux de pyrimidine et de purine, leur procédé de préparation et compositions pharmaceutiques les contenant

1995
- 1995-07-10 PE PE1995273436A patent/PE32296A1/es not_active IP Right Cessation
- 1995-07-19 DE DE69509173T patent/DE69509173T2/de not_active Expired - Lifetime
- 1995-07-19 DE DE0694547T patent/DE694547T1/de active Pending
- 1995-07-19 ES ES95111319T patent/ES2083348T3/es not_active Expired - Lifetime
- 1995-07-19 DK DK95111319T patent/DK0694547T3/da active
- 1995-07-19 AT AT95111319T patent/ATE179173T1/de active
- 1995-07-19 EP EP95111319A patent/EP0694547B1/fr not_active Expired - Lifetime
- 1995-07-19 DE DE2002199032 patent/DE10299032I2/de active Active
- 1995-07-21 TR TR95/00895A patent/TR199500895A2/xx unknown
- 1995-07-26 HU HU9502238A patent/HU216867B/hu unknown
- 1995-07-26 NZ NZ272652A patent/NZ272652A/en not_active IP Right Cessation
- 1995-07-26 MA MA23971A patent/MA23631A1/fr unknown
- 1995-07-26 CA CA002154721A patent/CA2154721C/fr not_active Expired - Lifetime
- 1995-07-26 ZA ZA956228A patent/ZA956228B/xx unknown
- 1995-07-26 IL IL114735A patent/IL114735A/en not_active IP Right Cessation
- 1995-07-26 AU AU27195/95A patent/AU697107B2/en not_active Expired
- 1995-07-27 CN CN95109671A patent/CN1045089C/zh not_active Expired - Lifetime
- 1995-07-27 RU RU95113148A patent/RU2133749C1/ru active
- 1995-07-27 TW TW084107779A patent/TW434242B/zh not_active IP Right Cessation
- 1995-07-27 KR KR1019950022600A patent/KR100358626B1/ko not_active Expired - Lifetime
- 1995-07-27 NO NO19952977A patent/NO312899B1/no not_active IP Right Cessation
- 1995-07-27 CO CO95033418A patent/CO4410181A1/es unknown
- 1995-07-27 MY MYPI95002156A patent/MY114393A/en unknown
- 1995-07-27 PL PL95309812A patent/PL180609B1/pl unknown
- 1995-07-27 FI FI953592A patent/FI112080B/fi active Protection Beyond IP Right Term
- 1995-07-27 BR BR9503468A patent/BR9503468A/pt active Search and Examination
- 1995-07-27 JP JP07190953A patent/JP3090305B2/ja not_active Expired - Lifetime
- 1995-07-27 CZ CZ19951939A patent/CZ290511B6/cs not_active IP Right Cessation
- 1995-07-27 UY UY24006A patent/UY24006A1/es not_active IP Right Cessation
- 1995-08-14 SA SA95160158A patent/SA95160158B1/ar unknown
1996
- 1996-04-30 GR GR960300021T patent/GR960300021T1/el unknown
1998
- 1998-12-15 HK HK98113443A patent/HK1012339A1/xx not_active IP Right Cessation
1999
- 1999-07-02 GR GR990401760T patent/GR3030678T3/el unknown
2000
- 2000-08-10 CY CY0000039A patent/CY2180B1/xx unknown
2001
- 2001-11-23 NL NL300071C patent/NL300071I2/nl unknown
2003
- 2003-01-10 NO NO2003001C patent/NO2003001I2/no unknown
- 2003-05-21 LU LU91136C patent/LU91136I2/fr unknown
2004
- 2004-10-20 CY CY200400003C patent/CY2004003I2/el unknown

Also Published As

Publication number	Publication date
IL114735A0 (en)	1995-11-27
CA2154721A1 (fr)	1996-01-29
DE694547T1 (de)	1996-10-24
DE69509173D1 (de)	1999-05-27
EP0694547B1 (fr)	1999-04-21
CY2004003I1 (el)	2009-11-04
NL300071I2 (nl)	2002-03-01
HU9502238D0 (en)	1995-09-28
HU216867B (hu)	1999-09-28
RU95113148A (ru)	1997-06-27
ES2083348T1 (es)	1996-04-16
CY2180B1 (en)	2002-08-23
TR199500895A2 (tr)	1996-06-21
PL309812A1 (en)	1996-02-05
DE10299032I2 (de)	2006-06-14
AU697107B2 (en)	1998-09-24
DE69509173T2 (de)	1999-10-21
PE32296A1 (es)	1996-08-07
CO4410181A1 (es)	1997-01-09
FI112080B (fi)	2003-10-31
SA95160158B1 (ar)	2006-05-20
MY114393A (en)	2002-10-31
LU91136I2 (fr)	2005-07-06
JP3090305B2 (ja)	2000-09-18
CY2004003I2 (el)	2009-11-04
PL180609B1 (pl)	2001-03-30
NL300071I1 (nl)	2002-02-01
ATE179173T1 (de)	1999-05-15
GR960300021T1 (en)	1996-04-30
NO2003001I2 (no)	2007-06-11
MA23631A1 (fr)	1996-04-01
JPH0841061A (ja)	1996-02-13
EP0694547A2 (fr)	1996-01-31
KR100358626B1 (ko)	2003-01-14
CZ290511B6 (cs)	2002-08-14
AU2719595A (en)	1996-02-08
DE10299032I1 (de)	2003-01-23
CN1122804A (zh)	1996-05-22
EP0694547A3 (fr)	1996-06-05
FI953592A0 (fi)	1995-07-27
UY24006A1 (es)	2001-07-31
NZ272652A (en)	1996-12-20
ES2083348T3 (es)	1999-08-01
IL114735A (en)	1998-06-15
DK0694547T3 (da)	2000-01-03
CA2154721C (fr)	2001-01-02
HUT73246A (en)	1996-07-29
BR9503468A (pt)	1996-02-27
CN1045089C (zh)	1999-09-15
TW434242B (en)	2001-05-16
NO952977D0 (no)	1995-07-27
HK1012339A1 (en)	1999-07-30
GR3030678T3 (en)	1999-11-30
CZ193995A3 (en)	1996-02-14
ZA956228B (en)	1996-02-22
KR960004345A (ko)	1996-02-23
NO952977L (no)	1996-01-29
FI953592L (fi)	1996-01-29
RU2133749C1 (ru)	1999-07-27

Publication	Publication Date	Title
NO312899B1 (no)	2002-07-15	Aminodihydro-oksopurinyl-metoksypropandiolderivater
US5840891A (en)	1998-11-24	2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol derivative
AP160A (en)	1991-11-18	Therapeutic acyclic nucleosides.
CA2244680C (fr)	2005-09-13	Procede pour la preparation de derives de la purine
US5543414A (en)	1996-08-06	Achiral amino acid acyl esters of ganciclovir and its derivatives
KR100464692B1 (ko)	2005-06-21	비환식뉴클레오시드유도체및이를포함하는약제학적조성물
WO1997027195A9 (fr)	1997-10-30	Procede pour la preparation de derives de la purine
WO1997027194A1 (fr)	1997-07-31	Procede pour preparer des derives de la purine
ES2180923T5 (es)	2005-10-16	Proceso para la preparacion de derivados de purina.
JPH0564960B2 (fr)	1993-09-16
JPH0570467A (ja)	1993-03-23	アミノ酸置換チアゼトキノリン−３−カルボン酸誘導体
CN102464691A (zh)	2012-05-23	制备抗病毒组合物的方法及其中间体的应用

Legal Events

Date	Code	Title	Description
2003-01-27	SPCF	Filing of supplementary protection certificate	Free format text: PRODUCT NAME: VALGANCIKLOVIR; NAT. REG. NO/DATE: NO , 01-11894 20020411; FIRST REG. NO/DATE: NL , RVG 25992 20010920 Spc suppl protection certif: 2003001 Filing date: 20030110
2007-06-11	SPCG	Granted supplementary protection certificate	Free format text: PRODUCT NAME: VALGANCIKLOVIR; NAT. REG. NO/DATE: NO , 01-11894 20020411; FIRST REG. NO/DATE: NL , RVG 25992 20010920 Spc suppl protection certif: 2003001 Filing date: 20030110 Extension date: 20160920
2015-08-10	MK1K	Patent expired
2016-10-17	SPCX	Expiry of an spc	Spc suppl protection certif: 2003001